IGM Bio plunges as Wall Street downgrades on portfolio shakeup
IGM Biosciences (NASDAQ:IGMS) lost nearly two-thirds of its value on Friday after the company abandoned two antibody-based ...
Why MBLY Is Down 30% Since Tuesday
Mobileye (MBLY), which is retreating 5% today, has tumbled 30% since its appearance at the Consumer Electronics Show (CES) on ...